MedTrace Logo

Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease

NCT00351364 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2014-12-03

No results posted yet for this study

Summary

To evaluate the effect of the drug Montelukast on the brachial artery's function. By giving a drug like Montelukast, which blocks the effects of inflammation in the lungs arteries and controls asthma, we hope to see positive effects in other arteries such as in the heart.

Conditions

Interventions

DRUG

Montelukast Sodium

100 mg P.O. One time only

Sponsors & Collaborators

  • Foothills Interventional Cardiology Group

    collaborator UNKNOWN

  • University of Calgary

    lead OTHER

Principal Investigators

  • David Goodhart, MD · Foothills Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00351364 on ClinicalTrials.gov